esamorelin (TH9507)Research-Grade GHRH AnalogueTagline: GH Axis & Lipid Metabolism Research

Product Description

Tesamorelin (scientific designation TH9507) is a synthetic growth hormone–releasing hormone (GHRH) analogue engineered to selectively stimulate endogenous growth hormone secretion through pituitary GHRH receptor activation. Widely studied in metabolic and endocrine research, Tesamorelin has gained recognition for its role in body composition, lipid metabolism, visceral adiposity, and GH/IGF-1 axis regulation.

Researchers utilize Tesamorelin in laboratory and preclinical models involving:

• growth hormone signaling

• IGF-1 pathway research

• visceral fat metabolism

• body recomposition studies

• endocrine regulation

• metabolic syndrome research

• lipid metabolism investigations

Its receptor specificity and well-characterized pharmacokinetic profile have made Tesamorelin one of the most recognized peptides in advanced metabolic and physique-optimization research.

Why Researchers Choose Tesamorelin

• Selective GHRH analogue studied for physiologic GH release pathways

• Frequently researched for visceral fat and body composition mechanisms

• Relevant across endocrine, metabolic, and lipid metabolism studies

• High-purity formulation suitable for controlled laboratory applications

• Stable lyophilized peptide designed for research consistency

• Batch-tested for identity, purity, and reproducible experimental outcomes

Product Specifications

• Research Grade

• High-Purity Formulation

• Laboratory Tested

• Research Use Only

Important Notice

For laboratory and scientific research purposes only. Not for human consumption, veterinary use, medical treatment, or diagnostic applications. Must be 21 years or older to purchase.